Compose a new way to ask the same question. The new question must be asking the exact same thing as the original question does. Without any other information, you should be able to tell that the original question and the new question are the same. Preserve bracketed phrases in your new question. You can change the rest of the question provided the above requirements are satisfied. The new question must have a natural, fluent formulation, as if it were composed by a native English speaker. You will be given three pieces of information to help you create better questions. Those are: "Answer": the answer to the question, e.g., "Honolulu". "Answer Type": the type of the answer, e.g., "Location". "Auxiliary Information" is a detailed description of some concepts mentioned in the question, if any.

Example Input: original question: Which brewery produces [India pale ale] with IBU less than [54.0]?
answer: new holland brewing company
answer type: Brewery / Brand of beer.
auxiliary information: India pale ale is a hoppy beer style within the broader category of pale ale. The first known use of the term "India pale ale" is an advertisement in the Sydney Gazette and New South Wales Advertiser in 1829. It was also referred to as pale ale as prepared for India, India ale, pale India ale, or pale export India ale.
Example Output: What company makes [India pale ale] with IBU under [54.0]?

Example Input: original question: How many drug classes include [BCG vaccine]?
answer: 2
answer type: Drug class.
auxiliary information: A vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and immunotherapeutic activities. Although the mechanism of its anti-tumor activity is unclear, immunization with BCG vaccine likely activates a Th1 cytokine response that includes the induction of interferon. Vaccination with BCG vaccine may be immunoprotective against infection with Mycobacterium tuberculosis.
Example Output: [BCG vaccine] contains how many drug classes?

Example Input: original question: what Medical trial is associated with a Medical trial health authority with Medical trials [A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.]?
answer: evaluation of neuromuscular disease, role of antibodies in cognitive dysfunction in patients with systemic lupus erythematosus, amoxicillin for the treatment of pediatric autoimmune disorders associated with streptococcal infections...
answer type: Medical trial.
auxiliary information: The purpose of this study is to evaluate the benefits and safety of the antiviral drug ganciclovir (DHPG) given intravenously to treat newborn infants who are born infected with cytomegalovirus (CMV). CMV is a herpes virus that can infect most organs of the body, resulting in death in 10-30% of babies with symptoms of CMV. It can cause severe brain damage in a large percentage of surviving babies. Children in this study have a CMV infection of the central nervous system (CNS).The study will enroll 130 newborn infants 1 month of age or younger with CMV involving the CNS. Patients will be assigned randomly (like tossing a coin) to receive either DHPG or no study drug treatment. All babies in the study will receive standard of care treatment and clinical, diagnostic, laboratory, safety, and follow-up evaluations. Follow-up evaluations, including hearing and eye exams and developmental assessments, will be done periodically until the child reaches 5 years of age. The degree of improved hearing among surviving patients will be a primary measure of drug effectiveness.
Example Output:
What is the  Medical trial that is associated with a Medical trial health authority with Medical trials [A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.]?